MacroGenics logo

MacroGenics

MGNX | NASDAQ
Chart Builder DCF Calculator
$2.17
-$0.03 (-1.36%)
At close: Nov 16, 2026, 4:00 PM ET
$2.14
-$0.03 (-1.38%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.36%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
27
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #875/1021 (Top 86%)

Key Statistics

Market Data

Market Cap $138.68M
1D Range
1.94 2.22
52W Range
1.33 4.86

Valuation (TTM)

PE -2.68
PB 5.51
EV/EBITDA 0.94

Valuation (NTM)

Forward PE N/A
Forward PEG -0.06
Price Target $6.00
Loading financial charts...

Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The c...

Sector Healthcare
Industry Biotechnology
Employees 293
IPO Date Oct 10, 2013
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.34
Miss -7.92%
REV
$18.67M
Miss -52.36%
Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$6.00
Upside
+176.50%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.